China Sunsine Chemical Holdings Ltd - Phillip Securities 2019-08-08: Potential Growth From Pipeline Projects

CHINA SUNSINE CHEM HLDGS LTD. (SGX:CH8)

China Sunsine Chemical Holdings Ltd - Potential Growth From Pipeline Projects

CHINA SUNSINE CHEMICAL (SGX:CH8)'s 2Q19 revenue and net profit met our expectation.
Second record-high profit margin with a decent growth of volume (GPM and NPM: 34.7% and 21.4%). ASP yet to bottom.
Capacity expansion projects in the pipeline: 20,000 tonnes Accelerator TBBS and 60,000 tonnes Insoluble Sulphur (IS).
We maintain FY19e and FY20e EPS at 21.0 SG cents and 22.0 SG cents respectively. Based on the same required rate of return of 10%, we maintain our BUY recommendation with an unchanged target price of S$1.43.

China Sunsine's 2Q19 GPM and NPM arrived at 34.7% and 21.4%, compared to the record high of 36.7% and 27.2%* in 2Q18 respectively (1Q19 GPM and NPM: 34.3% and 16.0%).
Gross profit/tonne dropped 32.3% y-o-y or 4.5% q-o-q to RMB5,886/tonne during the period, which was owing to the narrow spread between ASP and raw material (main: aniline) prices. The spread fell by 19.1% y-o-y and 10.2% q-o-q to RMB11,400/tonne in 2Q19. The respective implied capacity utilisation rate of Accelerators, Insoluble Sulphur (IS), and Anti-oxidant arrived at 97.2%, 101.0%, and 104.0% in 2Q19. Therefore, the production lines were running full during the period.

The y-o-y plunge of performance in 2Q19 was due mainly to the phenomenally high ASP in 2Q18. The downtrend beginning in 3Q18 continued. However, the aniline price slightly recovered by 6% q-o-q to RMB5,200/tonne during the period.

Nonetheless, the timely and visionary capacity expansion initiated before the price correction mitigates the price headwinds. The company manages to deliver a healthy performance owing to the established buffers, including the quality products, solid and long-term relationship with clients, and leading market position. Therefore, we believe the company will deliver more than 30% GPM and 16% NPM in 2019.
The future growth still stems from the ramp-up of capacity, including 20,000 tonnes of Accelerator TBBS (scheduled in 2019/2020) and 60,000 tonnes of Insoluble Sulphur (IS) (under planning), and both can be internally funded. According to management, the rationale that choosing Insoluble Sulphur for the next production expansion is that
1. China still imports Insoluble Sulphur and
2. Insoluble Sulphur has the highest GPM (around 40%) among the category.
In the next couple of years, we foresee that China Sunsine’s performance will level up once the new production lines commence and ASP bottoms out.

We maintain FY19e and FY20e EPS at 21 SG cents and 22 SG cents respectively.
Based on the same required rate of return of 10%, we maintain our BUY recommendation with an unchanged target price of S$1.43.

Chen Guangzhi Phillip Securities Research | https://www.stocksbnb.com/ 2019-08-08

SGX Stock Analyst Report BUY MAINTAIN BUY 1.430 SAME 1.430